X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (22018) 22018
Book Review (3482) 3482
Publication (1305) 1305
Conference Proceeding (230) 230
Book Chapter (211) 211
Dissertation (82) 82
Magazine Article (58) 58
Newsletter (54) 54
Web Resource (32) 32
Book / eBook (24) 24
Paper (9) 9
Reference (9) 9
Data Set (7) 7
Trade Publication Article (4) 4
Newspaper Article (3) 3
Streaming Video (2) 2
Government Document (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (14907) 14907
humans (13584) 13584
dyslipidemia (12227) 12227
male (9265) 9265
female (8474) 8474
risk factors (7019) 7019
middle aged (6527) 6527
adult (5157) 5157
cholesterol (4438) 4438
aged (4335) 4335
obesity (3767) 3767
hypertension (3443) 3443
metabolic syndrome (3434) 3434
lipids (3273) 3273
dyslipidemias - drug therapy (3244) 3244
diabetes (3112) 3112
dyslipidemias - blood (2880) 2880
prevalence (2750) 2750
atherosclerosis (2748) 2748
dyslipidemias - epidemiology (2681) 2681
animals (2653) 2653
insulin resistance (2642) 2642
cardiovascular disease (2564) 2564
dyslipidemias - complications (2512) 2512
diabetes mellitus (2308) 2308
cardiovascular diseases (2280) 2280
dyslipidemias (2257) 2257
risk (2160) 2160
endocrinology & metabolism (2153) 2153
cardiac & cardiovascular systems (2145) 2145
cardiovascular-disease (2124) 2124
insulin-resistance (2077) 2077
lipids - blood (2071) 2071
research (2054) 2054
triglycerides - blood (2048) 2048
body mass index (2037) 2037
coronary-heart-disease (2016) 2016
cholesterol, ldl - blood (1900) 1900
triglycerides (1841) 1841
statins (1794) 1794
pharmacology & pharmacy (1776) 1776
cholesterol, hdl - blood (1718) 1718
disease (1688) 1688
cross-sectional studies (1683) 1683
lipoproteins (1678) 1678
health aspects (1658) 1658
adolescent (1625) 1625
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (1605) 1605
treatment outcome (1540) 1540
medicine, general & internal (1530) 1530
peripheral vascular disease (1507) 1507
mortality (1502) 1502
metabolism (1453) 1453
risk-factors (1446) 1446
inflammation (1422) 1422
analysis (1411) 1411
care and treatment (1399) 1399
hypolipidemic agents - therapeutic use (1356) 1356
cholesterol - blood (1352) 1352
blood pressure (1342) 1342
cardiovascular diseases - prevention & control (1333) 1333
prevention (1328) 1328
glucose (1311) 1311
type 2 diabetes (1296) 1296
hypertension - epidemiology (1293) 1293
young adult (1289) 1289
biomarkers - blood (1284) 1284
cardiovascular diseases - etiology (1262) 1262
low density lipoproteins (1243) 1243
nutrition & dietetics (1206) 1206
mice (1191) 1191
abridged index medicus (1184) 1184
biochemistry & molecular biology (1182) 1182
insulin (1180) 1180
dyslipidemias - metabolism (1160) 1160
medicine (1150) 1150
diet (1137) 1137
cardiovascular (1115) 1115
cardiovascular diseases - epidemiology (1109) 1109
physiological aspects (1101) 1101
oxidative stress (1097) 1097
association (1094) 1094
aged, 80 and over (1088) 1088
dyslipidemias - etiology (1058) 1058
hypercholesterolemia (1027) 1027
child (1024) 1024
dyslipidemias - diagnosis (1022) 1022
rats (1022) 1022
risk assessment (1003) 1003
density-lipoprotein cholesterol (1000) 1000
cardiovascular risk (996) 996
retrospective studies (984) 984
comorbidity (969) 969
population (952) 952
myocardial-infarction (932) 932
liver (916) 916
studies (910) 910
research article (901) 901
time factors (891) 891
metabolic disorders (884) 884
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (16) 16
Gerstein Science - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Scarborough Hospital - Online (2) 2
Mt Sinai Hospital - Online (1) 1
St. Michael's Hospital - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19840) 19840
Spanish (722) 722
Portuguese (376) 376
Russian (284) 284
French (271) 271
Chinese (207) 207
Japanese (159) 159
German (146) 146
Czech (121) 121
Polish (96) 96
Korean (83) 83
Italian (58) 58
Hungarian (32) 32
Turkish (28) 28
Romanian (18) 18
Croatian (17) 17
Slovak (14) 14
Ukrainian (13) 13
Persian (12) 12
Lithuanian (9) 9
Swedish (6) 6
Danish (4) 4
Finnish (4) 4
Slovenian (4) 4
Serbian (3) 3
Dutch (2) 2
Hebrew (2) 2
Icelandic (2) 2
Indonesian (2) 2
Arabic (1) 1
Bosnian (1) 1
Bulgarian (1) 1
Greek (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Web Resource
THE EFFECTS OF MENOPAUSE ON THE SERUM LIPID PROFILE OF NORMAL FEMALES OF SOUTH EAST NIGERIA, 12/2005
Dyslipidemia in menopause is a known feature in women, whether it leads to significant increase in the development of coronary heart disease (CHD) is still... 
Menopause, Dyslipidemia, Cholesterol
Journal
2019, ISBN 9781496347442
"Dyslipidemia: A Clinical Approach is intended as a low-cost, quick-reference, easy-to-navigate guide for a broad range of healthcare professionals that will... 
Dyslipidemias | therapy | diagnosis
Web Resource
Journal Article
JAMA, ISSN 0098-7484, 11/2016, Volume 316, Issue 19, pp. 1997 - 2007
Journal Article
Atherosclerosis, ISSN 0021-9150, 2016, Volume 246, pp. 243 - 250
Abstract Objective Since dyslipidaemia is one of the most important risk factors for coronary heart disease (CHD), lowering of LDL-cholesterol (LDL-C) causes... 
Cardiovascular | LDL-Cholesterol | EUROASPIRE | Secondary prevention | Non-HDL-Cholesterol | Coronary heart disease | Statins | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | LDL CHOLESTEROL | PERCEPTION | DENSITY-LIPOPROTEIN CHOLESTEROL | STATIN THERAPY | PREDICTORS | PERIPHERAL VASCULAR DISEASE | HDL-CHOLESTEROL | DYSLIPIDEMIA | PRIMARY PREVENTION | CARDIOVASCULAR RISK-FACTORS | Secondary Prevention - trends | Humans | Middle Aged | Patient Discharge | Coronary Disease - epidemiology | Male | Drug Utilization Review | Young Adult | Dyslipidemias - blood | Time Factors | Guideline Adherence - trends | Lipids - blood | Aged, 80 and over | Adult | Female | Drug Therapy, Combination | Dyslipidemias - diagnosis | Coronary Disease - blood | Dyslipidemias - drug therapy | Cross-Sectional Studies | Risk Assessment | Risk Factors | Europe - epidemiology | Treatment Outcome | Biomarkers - blood | Coronary Disease - diagnosis | Drug Prescriptions | Practice Patterns, Physicians' - trends | Dyslipidemias - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Adolescent | Coronary Disease - drug therapy | Aged | Healthcare Disparities - trends | Health Care Surveys | Practice Guidelines as Topic | Surveys | Medical research | Blood cholesterol | Cardiac patients | Low density lipoproteins | Mortality | Medicine, Experimental | Cardiovascular agents | Index Medicus
Journal Article
02/2013
Background: Obesity is an independent risk factor of preeclampsia with unknown mechanism and hyperlipidemia might be a probable case of it. Objective: The... 
Dyslipidemia | Pre-eclampsia | Overweight
Web Resource
PLoS ONE, ISSN 1932-6203, 04/2016, Volume 11, Issue 4, pp. e0153497 - e0153497
Non-alcoholic fatty liver disease (NAFLD) covers a spectrum of diseases from simple steatosis to non-alcoholic steatohepatitis, with approximately 20% risk of... 
DIAGNOSIS | AMERICAN ASSOCIATION | RECOMMENDATIONS | MULTIDISCIPLINARY SCIENCES | CONTROLLED ATTENUATION PARAMETER | MARKERS | STEATOHEPATITIS | MICRORNAS | HEPATIC STEATOSIS | EXPRESSION | PCR | Dyslipidemias - genetics | Up-Regulation | Liver - pathology | Cross-Sectional Studies | Dyslipidemias - complications | Non-alcoholic Fatty Liver Disease - genetics | Humans | Middle Aged | Male | Non-alcoholic Fatty Liver Disease - complications | Young Adult | Caenorhabditis elegans | Non-alcoholic Fatty Liver Disease - blood | Dyslipidemias - blood | Animals | Non-alcoholic Fatty Liver Disease - diagnosis | Adult | Female | MicroRNAs - blood | MicroRNAs - genetics | Dyslipidemias - diagnosis | Complications and side effects | MicroRNA | Fatty liver | Dyslipidemias | Physiological aspects | Genetic aspects | Research | Risk factors | Biotechnology | Correlation | Nuclear magnetic resonance--NMR | Transplants & implants | Liver | Dyslipidemia | Feasibility analysis | Liver cancer | Hepatitis | Ultrasonic imaging | Bioindicators | Obesity | Liver diseases | Medical imaging | Feasibility studies | MiRNA | Inflammation | Metabolism | Gene expression | Patients | Low density lipoprotein | Cholesterol | Lipoproteins (very low density) | Steatosis | Serum levels | Cirrhosis | Weight control | Biopsy | MicroRNAs | Fibrosis | Biomarkers | Diagnostic systems | Diabetes | Methods | Index Medicus | Nuclear magnetic resonance | NMR
Journal Article
Asian Journal of Pharmaceutical and Clinical Research, ISSN 0974-2441, 02/2018, Volume 11, Issue 2, pp. 410 - 412
Journal Article
Journal of Clinical Lipidology, ISSN 1933-2874, 2013, Volume 7, Issue 4, pp. 304 - 383
Journal Article
Lipids in Health and Disease, ISSN 1476-511X, 09/2018, Volume 17, Issue 1, pp. 208 - 208
Journal Article
Circulation, ISSN 0009-7322, 01/2018, Volume 137, Issue 4, pp. 338 - 350
BACKGROUND:The PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor evolocumab reduced low-density lipoprotein cholesterol and cardiovascular events... 
atherosclerosis | amputation | cholesterol, LDL | evolocumab | peripheral arterial disease | PCSK9 protein, human | intermittent claudication | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | LIMB ISCHEMIA | ATORVASTATIN | STATIN THERAPY | AMPUTATION-FREE SURVIVAL | PERIPHERAL VASCULAR DISEASE | POLYVASCULAR DISEASE | PEOPLE | SIMVASTATIN | ASSOCIATION | Dyslipidemias - mortality | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Serine Proteinase Inhibitors - therapeutic use | Dyslipidemias - blood | Time Factors | Serine Proteinase Inhibitors - adverse effects | Amputation | Peripheral Arterial Disease - blood | Cholesterol, LDL - blood | Female | Dyslipidemias - diagnosis | Dyslipidemias - drug therapy | Limb Salvage | Down-Regulation | Risk Factors | Treatment Outcome | Biomarkers - blood | Proprotein Convertase 9 - metabolism | Anticholesteremic Agents - adverse effects | Peripheral Arterial Disease - mortality | Peripheral Arterial Disease - therapy | Anticholesteremic Agents - therapeutic use | Peripheral Arterial Disease - diagnosis | Proprotein Convertase 9 - antagonists & inhibitors | Aged | Cholesterol, LDL | Care and treatment | Research | Peripheral vascular diseases | Cardiovascular diseases | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Lipidology, ISSN 1933-2874, 2015, Volume 9, Issue 2, pp. 129 - 169
Journal Article